Vertex Pharmaceuticals
VRTX
$292.55
Share price
3.19%
Change (1 day)
56.01%
Change (1 year)
Categories
Earnings for Vertex Pharmaceuticals (VRTX)
Earnings in 2022 (TTM): $2.92 B
According to Vertex Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $2.92 B. In 2021 the company made an earning of $2.79 B a decrease over its 2020 earnings that were of $3.17 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Vertex Pharmaceuticals from 2003 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $2.92 B | 4.77% |
| 2021 | $2.79 B | -12.06% |
| 2020 | $3.17 B | 118.45% |
| 2019 | $1.45 B | 129.12% |
| 2018 | $0.63 B | 1415.4% |
| 2017 | $0.04 B | 197.6% |
| 2016 | $0.01 B | -102.97% |
| 2015 | -$0.48 B | -28.53% |
| 2014 | -$0.67 B | -51.52% |
| 2013 | -$1.37 B | -32098.55% |
| 2012 | $4.27 M | |
| 2010 | -$0.74 B | 24.05% |
| 2009 | -$0.6 B | |
| 2007 | -$0.42 B | 83.1% |
| 2006 | -$0.23 B | 59.02% |
| 2005 | -$0.15 B | 3.28% |
| 2004 | -$0.14 B | -37.83% |
| 2003 | -$0.23 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.33 B | 629.55% | 🇺🇸 USA |
 AbbVie ABBV | $16.39 B | 460.35% | 🇺🇸 USA |
 Gilead Sciences GILD | $6.84 B | 133.99% | 🇺🇸 USA |
 Merck MRK | $16.60 B | 467.63% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $8.56 B | 192.72% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | -$0.14 B | -104.51% | 🇺🇸 USA |